RecruitingNot applicableNCT05978128
Official study title

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Study summary

This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedHealth Education and Health Promotion and Education

Plus 2 other study approaches.

Who it may be forBreast Carcinoma · Lung Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 10, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Jonsson Comprehensive Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
Jonsson Comprehensive Cancer Center
Interventions being studied
Behavioral: Health Education; Other: Health Promotion and Education; Behavioral: Patient Navigation; Other: Survey Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age:
  • Breast screening \> 40
  • Lung screening 50-80
  • Male (M) or Female (F)
  • Current, former, or never smokers
  • Close family or friend with smoking history (in or out of state)
Reasons someone may not be able to joinExclusion criteria
  • Age:
  • Breast screening \< 40
  • Lung screening \< 50 or \> 80
  • Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded
  • Persons with an active cancer

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • UCLA / Jonsson Comprehensive Cancer CenterLos Angeles, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 10, 2025. Always confirm current availability with the study team.

View original record ↗